These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2889359)

  • 1. Regulation of guanylate cyclase by atrial natriuretic factor and the role of cyclic GMP in vasodilation.
    Murad F; Leitman DC; Bennett BM; Molina C; Waldman SA
    Am J Med Sci; 1987 Sep; 294(3):139-43. PubMed ID: 2889359
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M; Arnal JF; Pham I; Gonzalez W; Lyoussi B; Michel JB
    Ann Endocrinol (Paris); 2000 Feb; 61(1):32-40. PubMed ID: 10790590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide.
    Murad F
    Biochem Soc Trans; 1988 Aug; 16(4):490-2. PubMed ID: 2850236
    [No Abstract]   [Full Text] [Related]  

  • 7. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
    Wright RS; Wei CM; Kim CH; Kinoshita M; Matsuda Y; Aarhus LL; Burnett JC; Miller WL
    J Am Coll Cardiol; 1996 Oct; 28(4):1031-8. PubMed ID: 8837586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM; Murad F
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular actions of atrial natriuretic peptide.
    Mulvany MJ
    Pharmacol Res Commun; 1988 Sep; 20 Suppl 3():23-34. PubMed ID: 2906437
    [No Abstract]   [Full Text] [Related]  

  • 10. cGMP: the wayward child of the cyclic nucleotide family.
    Goy MF
    Trends Neurosci; 1991 Jul; 14(7):293-9. PubMed ID: 1719676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms of action of atrial natriuretic factor.
    Gerzer R; Heim JM; Schütte B; Weil J
    Klin Wochenschr; 1987; 65 Suppl 8():109-14. PubMed ID: 2885440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
    Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
    J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
    Ijioma SC; Challiss RA; Boyle JP
    Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system.
    Böhme E; Schmidt HH
    Z Kardiol; 1989; 78 Suppl 6():75-9. PubMed ID: 2575829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of atrial natriuretic factor: clinical consequences.
    Gerzer R; Weil J; Strom T; Müller T
    Klin Wochenschr; 1986; 64 Suppl 6():21-6. PubMed ID: 2879064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of atrial natriuretic factor on cyclic GMP synthesis in rat vascular smooth muscle cells in culture].
    Takeuchi K; Abe K; Sato M; Yasujima M; Omata K; Tanno M; Kozuki M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1987 Jan; 29(1):29-39. PubMed ID: 2884337
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory action of alpha-human atrial natriuretic peptide on noradrenaline-induced synthesis of myo-inositol 1,4,5-trisphosphate in the smooth muscle cells of rabbit aorta.
    Kajikuri J; Kuriyama H
    Br J Pharmacol; 1990 Mar; 99(3):536-40. PubMed ID: 1970498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries.
    Eskinder H; Hillard CJ; Flynn N; Bosnjak ZJ; Kampine JP
    Anesthesiology; 1992 Sep; 77(3):482-7. PubMed ID: 1355637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
    Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
    J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of atrial natriuretic peptide on cyclic GMP system in vascular smooth muscle.
    Mittal CK
    Indian J Exp Biol; 1987 Jan; 25(1):24-8. PubMed ID: 2886423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.